Oric Pharmaceuticals, Inc. Common Stock

ORICNASDAQUSD
9.53 USD
0.07 (0.74%)AT CLOSE (11:59 AM EDT)
9.22
0.32 (3.31%)
POST MARKET (AS OF 08:00 PM EDT)
Post Market
AS OF 08:00 PM EDT
9.22
0.32 (3.31%)
🔴Market: CLOSED

Shares of Oric Pharmaceuticals, Inc. Common Stock (ORIC) are trading at $9.53. The technical outlook is "Strong Buy" and the fundamental picture shows "Neutral". Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.

Technical & fundamental data as of Jun 26, 2026.

Open?$9.46
High?$9.74
Low?$9.27
Prev. Close?$9.46
Volume?3.8M
Avg. Volume?1.8M
VWAP?$9.49
Rel. Volume?2.09x
Bid / Ask
Bid?$7.60 × 100
Ask?$9.47 × 200
Spread?$1.87
Midpoint?$8.54
Valuation & Ratios
Market Cap?986.5M
Shares Out?103.5M
Float?58.1M
Float %?59.7%
P/E Ratio?N/A
P/B Ratio?2.37
EPS?-$1.31
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
Employees
104
Market Cap
979.3M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2020-04-24
Address
240 E. GRAND AVE.
SOUTH SAN FRANCISCO, CA 94080
Phone: (650) 388-5600
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bullish(+1/3)
Medium-Term (Wave)? Bullish(+2/3)
Short-Term (Ripple)? Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
50
Short Sent.?
30
Piotroski F-Score?0/9Weak
Altman Z-Score?25.20Safe
Confidence?45%Low
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?36.24%Squeeze Risk
Short Interest?21.1M
Days to Cover?10.3
Free Float58.1M
Avg Daily Volume2.0M
Settlement Date2026-06-15
Financial Health
Current Ratio?16.33Strong
Quick Ratio?16.33Strong
Cash Ratio?3.17Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A
P/B?
Peers
100
S&P
67
2.37CHEAP
P/S?
N/A
P/FCF?
N/A
EV/EBITDA?
S&P
97
-6.3CHEAP
EV/Sales?
N/A
Returns & Efficiency
ROE?
S&P
6
-32.5%WEAK
ROA?
S&P
3
-31.0%WEAK
Cash Flow & Enterprise
FCF?$-111202000
Enterprise Value?$930.1M
Fundamentals ratios updated end of day